265: Novavax's CEO promises a turnaround & how Lilly roiled the obesity market

1

Introduction

00:00 • 2min

2

The Rise and Fall of the Next-Generation Obesity Drug

01:53 • 2min

3

Reddit TrueTide: The Triple G Drug for Weight Loss

03:35 • 2min

4

The Future of Obesity Drugs

05:15 • 2min

5

The Future of Samagletide

07:01 • 2min

6

The Impact of Obesity Medicines on Drug Development

08:36 • 2min

7

The Newfangled Obesity Drug Story

10:24 • 2min

8

Pfizer's Discontinuation of Trials of Small Molecule Pills

12:01 • 2min

9

Novavax's Success During the Pandemic Turned Its Fortunes Around

13:55 • 3min

10

Novavax's CEO: John Jacobs

16:45 • 2min

11

Novavax's Challenges

18:27 • 2min

12

How to Cut Expenses for the Future of Novex

20:13 • 2min

13

How New Vaxx Can Be a Bigger Vaccine Player

21:59 • 2min

14

Novavax's Future

23:36 • 2min

15

Novak's Warning About Gavi Going Concern

25:35 • 2min

16

Novak's Is a Meme Stock Before There Were Meme Stocks

27:08 • 2min

17

The Risks of Failure

28:43 • 2min

18

The Relationship With the Employee Base

30:21 • 1min

19

The Importance of Listening and Connecting

31:47 • 3min